Economics of Innovation - OHE - Page 3

We found for

Key-Learnings-small

Insight
April 2021

Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic

Insight
March 2021

Time to Tackle the Challenges around Combination Therapies for Cancer

Insight
March 2021

Does Government Funding Increase Public Sector Development of New Medicines?

It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?

Read more

Payment Models for Multi-Indication Therapies

Read more

© Photology1971/Shutterstock

Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making

Read more

The Lower Drug Costs Now Act and Pharmaceutical Innovation

Read more

Insight
January 2021

Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments

Key Considerations for Early Access Schemes for Single-Administration (One-Time) Therapies

Read more

Exploring the Financial Sustainability of Gene Therapies

Read more

© Sergey Nivens

The Promise of Gene Therapies: Are We Ready?

Read more

Insight
December 2020

The Value of Diagnostic information (VODI) in Heart Failure – Recognising Value Beyond ‘Beats-Per-Minute’

News
October 2020

Opportunities to Increase Efficiency in Healthcare

News
September 2020

Establishing a Reasonable Price for an Orphan Drug

Insight
July 2020

How Should the World Pay for a COVID-19 Vaccine?

Danzon_Patricia_1305 (1)

News
June 2020

Victor R. Fuchs Award for 2020 Goes to Patricia Danzon

01
02
03
04
05
06
07
00